Selected article for: "CCR2 expression and cell line"
Author: Teixeira, P. C.; Dorneles, G. P.; de Santana Filho, P. C.; da Silva, I. M.; Schipper, L. d. L.; Postiga, I. A. d. L.; Neves, C. A. M.; Junior, L. C. R.; Peres, A.; de Souto, J. T.; Fonseca, S. G. d.; Eller, S.; Oliveira, T. F.; Rotta, L.; Thompson, C. E.; Romao, P. R. T.
Title: Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.
  • Cord-id: j6vyatv1
  • Document date: 2021_6_27
    • ID: j6vyatv1
    Snippet: This study aimed to evaluate the link between microbial translocation markers and systemic inflammation at the earliest time-point after hospitalization and at the last 72 h of hospitalization in survivors and non-survivors COVID-19 patients. Sixty-six SARS-CoV-2 RT-PCR+ infected patients and nine non-COVID-19 pneumonia controls were admitted in this study. Blood samples were collected at hospital admission (T1) (Controls and COVID-19+ patients) and 0-72 h before hospital discharge (T2, alive or
    Document: This study aimed to evaluate the link between microbial translocation markers and systemic inflammation at the earliest time-point after hospitalization and at the last 72 h of hospitalization in survivors and non-survivors COVID-19 patients. Sixty-six SARS-CoV-2 RT-PCR+ infected patients and nine non-COVID-19 pneumonia controls were admitted in this study. Blood samples were collected at hospital admission (T1) (Controls and COVID-19+ patients) and 0-72 h before hospital discharge (T2, alive or dead) to analyze systemic cytokines and chemokines, LPS concentrations, and soluble CD14 (sCD14) levels. THP-1 human monocytic cell line was incubated with plasma from survivors and non-survivors COVID-19 patients and their phenotype, activation status, TLR4, and chemokine receptors were analyzed by flow cytometry. COVID-19 patients presented higher IL-6, IFN-{gamma}, TNF-, TGF-{beta}1, CCL2/MCP-1, CCL4/MIP-1{beta}, and CCL5/RANTES levels than controls. Moreover, LPS and sCD14 were higher at hospital admission in SARS-CoV-2-infected patients. Non-survivors COVID-19 patients had increased LPS levels concomitant with higher IL-6, TNF-, CCL2/MCP-1, and CCL5/RANTES levels at T2. Increased expression of CD16 and CCR5 were identified in THP-1 cells incubated with the plasma of survivor patients obtained at T2. The incubation of THP-1 with T2 plasma of non-survivors COVID-19 leads to higher TLR4, CCR2, CCR5, CCR7, and CD69 expression. In conclusion, increased microbial translocation during hospitalization coexist with the inflammatory condition of SARS-CoV-2 infection and could lead to higher monocyte activation in non-survivors COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and local response: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lps increase: 1, 2
    • acute ards respiratory distress syndrome and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lps stimulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute ards respiratory distress syndrome and lps translocation: 1
    • acute ards respiratory distress syndrome and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung infection cause: 1, 2
    • acute ards respiratory distress syndrome and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • local response and lps lipopolysaccharide: 1
    • local response and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • local response and lung infection cause: 1
    • local response and lung inflammation: 1, 2, 3, 4, 5, 6
    • lps increase and lung inflammation: 1, 2
    • lps lipopolysaccharide and lung infection: 1, 2, 3, 4, 5, 6, 7
    • lps lipopolysaccharide and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lps lipopolysaccharide and lymphocyte activation: 1
    • lps stimulation and lung inflammation: 1, 2, 3, 4
    • lps translocation and lung inflammation: 1, 2
    • lung infection and lymphocyte activation: 1, 2, 3